PHARMACYTE BIOTECH, INC. Increase (Decrease) in Accounts Payable
PHARMACYTE BIOTECH, INC. (PMCB) reported Increase (Decrease) in Accounts Payable of $355.92 thousand for the 9-month period ending 2024-01-31, per its 10-Q filed 2024-03-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2024-03-18
- PHARMACYTE BIOTECH, INC. increase (decrease) in accounts payable for the quarter ending 2024-01-31 was $358.04K.
- PHARMACYTE BIOTECH, INC. increase (decrease) in accounts payable for the quarter ending 2023-10-31 was -$591.97K, a 295.85% decline year-over-year.
- PHARMACYTE BIOTECH, INC. increase (decrease) in accounts payable for the quarter ending 2023-07-31 was $589.85K, a 66.78% increase year-over-year.
- PHARMACYTE BIOTECH, INC. increase (decrease) in accounts payable for the quarter ending 2023-04-30 was -$317.65K, a 382.36% decline year-over-year.
- PHARMACYTE BIOTECH, INC. increase (decrease) in accounts payable for fiscal 2023 was -$242.95K, a 833.98% decline from fiscal 2022.
- PHARMACYTE BIOTECH, INC. increase (decrease) in accounts payable for fiscal 2022 was $33.10K.
- PHARMACYTE BIOTECH, INC. increase (decrease) in accounts payable for fiscal 2021 was -$13.58K, a 121.23% decline from fiscal 2020.
- PHARMACYTE BIOTECH, INC. increase (decrease) in accounts payable for fiscal 2020 was $63.96K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|
| 2024-01-31 | $358.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-03-18 | -$233.93K derived: sum of 2 quarters · filed 2024-03-18 | $355.92K 10-Q · filed 2024-03-18 | $38.26K derived: sum of 4 quarters · filed 2024-03-18 | |
| 2023-10-31 | -$591.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-12-15 | -$2.12K 10-Q · filed 2023-12-15 | -$319.77K derived: sum of 3 quarters · filed 2023-12-15 | -$900.98K derived: sum of 4 quarters · filed 2024-03-18 | |
| 2023-07-31 | $589.85K 10-Q · filed 2023-09-18 | $272.19K derived: sum of 2 quarters · filed 2023-09-18 | -$309.01K derived: sum of 3 quarters · filed 2024-03-18 | -$6.76K derived: sum of 4 quarters · filed 2024-03-18 | |
| 2023-04-30 | -$317.65K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-31 | -$898.86K derived: sum of 2 quarters · filed 2024-03-18 | -$596.61K derived: sum of 3 quarters · filed 2024-03-18 | -$242.95K 10-K · filed 2023-07-31 | |
| 2023-01-31 | -$581.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-03-18 | -$278.96K derived: sum of 2 quarters · filed 2024-03-18 | $74.71K 10-Q · filed 2024-03-18 | $187.21K derived: sum of 4 quarters · filed 2024-03-18 | |
| 2022-10-31 | $302.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-12-15 | $655.92K 10-Q · filed 2023-12-15 | $768.41K derived: sum of 3 quarters · filed 2023-12-15 | $704.24K derived: sum of 4 quarters · filed 2023-12-15 | |
| 2022-07-31 | $353.67K 10-Q · filed 2023-09-18 | $466.16K derived: sum of 2 quarters · filed 2023-09-18 | $401.99K derived: sum of 3 quarters · filed 2023-09-18 | $393.28K derived: sum of 4 quarters · filed 2023-09-18 | |
| 2022-04-30 | $112.50K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-31 | $48.32K derived: sum of 2 quarters · filed 2023-07-31 | $39.62K derived: sum of 3 quarters · filed 2023-07-31 | $33.10K 10-K · filed 2023-07-31 | |
| 2022-01-31 | -$64.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-16 | -$72.88K derived: sum of 2 quarters · filed 2023-03-16 | -$79.40K 10-Q · filed 2023-03-16 | $13.70K derived: sum of 4 quarters · filed 2023-03-16 | |
| 2021-10-31 | -$8.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-12-14 | -$15.22K 10-Q · filed 2022-12-14 | $77.88K derived: sum of 3 quarters · filed 2022-12-14 | $76.92K derived: sum of 4 quarters · filed 2022-12-14 | |
| 2021-07-31 | -$6.52K 10-Q · filed 2022-09-14 | $86.58K derived: sum of 2 quarters · filed 2022-09-14 | $85.63K derived: sum of 3 quarters · filed 2022-09-14 | -$219.09K derived: sum of 4 quarters · filed 2022-09-14 | |
| 2021-04-30 | $93.10K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-28 | $92.14K derived: sum of 2 quarters · filed 2022-07-28 | -$212.57K derived: sum of 3 quarters · filed 2022-07-28 | -$13.58K 10-K · filed 2022-07-28 | |
| 2021-01-31 | -$957.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-15 | -$305.67K derived: sum of 2 quarters · filed 2022-03-15 | -$106.68K 10-Q · filed 2022-03-15 | -$261.33K derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-10-31 | -$304.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-14 | -$105.72K 10-Q · filed 2021-12-14 | -$260.38K derived: sum of 3 quarters · filed 2021-12-14 | -$84.46K derived: sum of 4 quarters · filed 2021-12-14 | |
| 2020-07-31 | $198.99K 10-Q · filed 2021-09-14 | $44.34K derived: sum of 2 quarters · filed 2021-09-14 | $220.25K derived: sum of 3 quarters · filed 2021-09-14 | $317.29K derived: sum of 4 quarters · filed 2021-09-14 | |
| 2020-04-30 | -$154.65K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-10 | $21.26K derived: sum of 2 quarters · filed 2021-08-10 | $118.30K derived: sum of 3 quarters · filed 2021-08-10 | $63.96K 10-K · filed 2021-08-10 | |
| 2020-01-31 | $175.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-12 | $272.94K derived: sum of 2 quarters · filed 2021-03-12 | $218.61K 10-Q · filed 2021-03-12 | $206.82K derived: sum of 4 quarters · filed 2021-03-12 | |
| 2019-10-31 | $97.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-11 | $42.70K 10-Q · filed 2020-12-11 | $30.91K derived: sum of 3 quarters · filed 2020-12-11 | -$184.06K derived: sum of 4 quarters · filed 2020-12-11 | |
| 2019-07-31 | -$54.34K 10-Q · filed 2020-09-11 | -$66.13K derived: sum of 2 quarters · filed 2020-09-11 | -$281.09K derived: sum of 3 quarters · filed 2020-09-11 | -$507.47K derived: sum of 4 quarters · filed 2020-09-11 | |
| 2019-04-30 | -$11.79K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-13 | -$226.75K derived: sum of 2 quarters · filed 2020-08-13 | -$453.13K derived: sum of 3 quarters · filed 2020-08-13 | -$230.74K 10-K · filed 2020-08-13 | |
| 2019-01-31 | -$214.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-03-13 | -$441.34K derived: sum of 2 quarters · filed 2020-03-13 | -$218.94K 10-Q · filed 2020-03-13 | -$171.92K derived: sum of 4 quarters · filed 2020-03-13 | |
| 2018-10-31 | -$226.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-23 | -$3.98K 10-Q · filed 2019-12-23 | $43.05K derived: sum of 3 quarters · filed 2019-12-23 | $37.83K derived: sum of 4 quarters · filed 2019-12-23 | |
| 2018-07-31 | $222.39K 10-Q · filed 2019-09-13 | $269.42K derived: sum of 2 quarters · filed 2019-09-13 | $264.21K derived: sum of 3 quarters · filed 2019-09-13 | -$53.17K derived: sum of 4 quarters · filed 2019-09-13 | |
| 2018-04-30 | $47.03K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-13 | $41.81K derived: sum of 2 quarters · filed 2019-08-13 | -$275.56K derived: sum of 3 quarters · filed 2019-08-13 | -$12.98K 10-K · filed 2019-08-13 | |
| 2018-01-31 | -$5.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-14 | -$322.59K derived: sum of 2 quarters · filed 2019-03-14 | -$60.01K 10-Q · filed 2019-03-14 | -$129.41K derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-10-31 | -$317.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-14 | -$54.79K 10-Q · filed 2018-12-14 | -$124.19K derived: sum of 3 quarters · filed 2018-12-14 | $9.91K derived: sum of 4 quarters · filed 2018-12-14 | |
| 2017-07-31 | $262.58K 10-Q · filed 2018-09-12 | $193.18K derived: sum of 2 quarters · filed 2018-09-12 | $327.29K derived: sum of 3 quarters · filed 2018-09-12 | $316.56K derived: sum of 4 quarters · filed 2018-09-12 | |
| 2017-04-30 | -$69.40K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-20 | $64.70K derived: sum of 2 quarters · filed 2018-07-20 | $53.97K derived: sum of 3 quarters · filed 2018-07-20 | $29.59K 10-K · filed 2018-07-20 | |
| 2017-01-31 | $134.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | $123.37K derived: sum of 2 quarters · filed 2018-03-19 | $98.99K 10-Q · filed 2018-03-19 | -$262.32K derived: sum of 4 quarters · filed 2018-03-19 | |
| 2016-10-31 | -$10.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-14 | -$35.11K 10-Q · filed 2017-12-14 | -$396.43K derived: sum of 3 quarters · filed 2017-12-14 | -$126.31K derived: sum of 4 quarters · filed 2017-12-14 | |
| 2016-07-31 | -$24.38K 10-Q · filed 2017-09-13 | -$385.69K derived: sum of 2 quarters · filed 2017-09-13 | -$115.58K derived: sum of 3 quarters · filed 2017-09-13 | -$101.49K derived: sum of 4 quarters · filed 2017-09-13 | |
| 2016-04-30 | -$361.31K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-27 | -$91.20K derived: sum of 2 quarters · filed 2017-07-27 | -$77.11K derived: sum of 3 quarters · filed 2017-07-27 | -$160.69K 10-K · filed 2017-07-27 | |
| 2016-01-31 | $270.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-13 | $284.20K derived: sum of 2 quarters · filed 2017-03-13 | $200.62K 10-Q · filed 2017-03-13 | $321.53K derived: sum of 4 quarters · filed 2017-03-13 | |
| 2015-10-31 | $14.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-02 | -$69.49K 10-Q · filed 2016-12-02 | $51.41K derived: sum of 3 quarters · filed 2016-12-02 | $155.10K derived: sum of 4 quarters · filed 2016-12-02 | |
| 2015-07-31 | -$83.58K 10-Q · filed 2016-09-06 | $37.32K derived: sum of 2 quarters · filed 2016-09-06 | $141.00K derived: sum of 3 quarters · filed 2016-09-06 | $208.75K derived: sum of 4 quarters · filed 2016-09-06 | |
| 2015-04-30 | $120.91K derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $224.59K derived: sum of 2 quarters · filed 2016-07-29 | $292.33K derived: sum of 3 quarters · filed 2016-07-29 | $308.65K 10-K · filed 2016-07-29 | |
| 2015-01-31 | $103.68K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-03-08 | $171.42K derived: sum of 2 quarters · filed 2016-03-08 | $187.75K 10-Q · filed 2016-03-08 | $187.28K derived: sum of 4 quarters · filed 2016-07-29 | |
| 2014-10-31 | $67.74K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2016-01-19 | $84.07K 10-Q/A · filed 2016-01-19 | $83.60K derived: sum of 3 quarters · filed 2016-07-29 | $33.75K derived: sum of 4 quarters · filed 2016-07-29 | |
| 2014-07-31 | $16.33K 10-Q/A · filed 2016-01-19 | $15.86K derived: sum of 2 quarters · filed 2016-07-29 | -$33.99K derived: sum of 3 quarters · filed 2016-07-29 | -$43.83K derived: sum of 4 quarters · filed 2016-07-29 | |
| 2014-04-30 | -$467.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | -$50.31K derived: sum of 2 quarters · filed 2016-07-29 | -$60.16K derived: sum of 3 quarters · filed 2016-07-29 | -$59.19K 10-K · filed 2016-07-29 | |
| 2014-01-31 | -$49.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-13 | -$59.69K derived: sum of 2 quarters · filed 2015-03-13 | -$58.72K 10-Q · filed 2015-03-13 | -$59.00K derived: sum of 4 quarters · filed 2016-01-19 | |
| 2013-10-31 | -$9.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | -$8.88K 10-Q · filed 2014-12-15 | -$9.16K derived: sum of 3 quarters · filed 2016-01-19 | $7.71K derived: sum of 4 quarters · filed 2016-01-19 | |
| 2013-07-31 | $965.00 10-Q · filed 2014-09-15 | $685.00 derived: sum of 2 quarters · filed 2016-01-19 | $17.55K derived: sum of 3 quarters · filed 2016-01-19 | $80.12K derived: sum of 4 quarters · filed 2016-01-19 | |
| 2013-04-30 | -$280.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-01-19 | $16.58K derived: sum of 2 quarters · filed 2016-01-19 | $79.16K derived: sum of 3 quarters · filed 2016-01-19 | $97.71K 10-K/A · filed 2016-01-19 | |
| 2013-01-31 | $16.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $79.44K derived: sum of 2 quarters · filed 2014-03-17 | $97.99K 10-Q · filed 2014-03-17 | $303.86K derived: sum of 4 quarters · filed 2014-03-17 | |
| 2012-10-31 | $62.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-16 | $81.13K 10-Q · filed 2013-12-16 | $286.99K derived: sum of 3 quarters · filed 2013-12-16 | $257.74K derived: sum of 4 quarters · filed 2013-12-16 | |
| 2012-07-31 | $18.55K 10-Q · filed 2013-09-16 | -$124.94K 10-Q · filed 2012-09-19 | $224.42K derived: sum of 2 quarters · filed 2013-09-16 | $195.16K derived: sum of 3 quarters · filed 2013-09-16 | $205.58K derived: sum of 4 quarters · filed 2013-09-16 |
| 2012-04-30 | $205.87K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | $176.61K derived: sum of 2 quarters · filed 2013-07-29 | $187.03K derived: sum of 3 quarters · filed 2013-07-29 | $173.82K 10-K · filed 2013-07-29 | |
| 2012-01-31 | -$29.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-26 | -$18.84K derived: sum of 2 quarters · filed 2013-03-26 | -$32.04K 10-Q · filed 2013-03-26 | -$74.99K derived: sum of 4 quarters · filed 2013-03-26 | |
| 2011-10-31 | $10.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-26 | -$2.79K 10-Q · filed 2012-12-26 | -$45.73K derived: sum of 3 quarters · filed 2012-12-26 | -$36.91K derived: sum of 4 quarters · filed 2012-12-26 | |
| 2011-07-31 | -$13.21K 10-Q · filed 2012-09-19 | -$56.16K derived: sum of 2 quarters · filed 2012-09-19 | -$47.33K derived: sum of 3 quarters · filed 2012-09-19 | -$33.60K derived: sum of 4 quarters · filed 2012-09-19 | |
| 2011-04-30 | -$42.95K derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-14 | -$34.12K derived: sum of 2 quarters · filed 2012-08-14 | -$20.39K derived: sum of 3 quarters · filed 2012-08-14 | $30.94K 10-K · filed 2012-08-14 | |
| 2011-01-31 | $8.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-21 | $22.56K derived: sum of 2 quarters · filed 2012-03-21 | $73.89K 10-Q · filed 2012-03-21 | ||
| 2010-10-31 | $13.73K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2011-12-15 | $65.06K 10-Q · filed 2011-12-15 | |||
| 2010-07-31 | $51.33K 10-Q/A · filed 2011-09-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |